Cargando…

Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy

Standard treatment of optic pathways gliomas consists of radiotherapy and surgery when feasible. Owing to the toxicity of irradiation, chemotherapy has emerged as an interesting therapeutic option, especially in young children. This study describes the neuropsychological profile of 27 children (aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacaze, E, Kieffer, V, Streri, A, Lorenzi, C, Gentaz, E, Habrand, J-L, Dellatolas, G, Kalifa, C, Grill, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376861/
https://www.ncbi.nlm.nih.gov/pubmed/14647135
http://dx.doi.org/10.1038/sj.bjc.6601410
_version_ 1782154746458537984
author Lacaze, E
Kieffer, V
Streri, A
Lorenzi, C
Gentaz, E
Habrand, J-L
Dellatolas, G
Kalifa, C
Grill, J
author_facet Lacaze, E
Kieffer, V
Streri, A
Lorenzi, C
Gentaz, E
Habrand, J-L
Dellatolas, G
Kalifa, C
Grill, J
author_sort Lacaze, E
collection PubMed
description Standard treatment of optic pathways gliomas consists of radiotherapy and surgery when feasible. Owing to the toxicity of irradiation, chemotherapy has emerged as an interesting therapeutic option, especially in young children. This study describes the neuropsychological profile of 27 children (aged between 1.5 and 15.7 years) with optic pathways gliomas treated with chemotherapy as first-line treatment. Eight of them also received radiotherapy as salvage treatment. Eight had neurofibromatosis type 1 (NF1). Intellectual outcome was preserved in children treated with chemotherapy only (mean=107±17) compared to children also receiving radiotherapy (mean IQ=88±24) or children having NF1 and treated with chemotherapy (mean IQ=80±13). Scores for abstract reasoning, mental arithmetic, chessboard/coding, perception, judgement of line orientation were lower in children irradiated than in those treated only by chemotherapy. Children with Nf1 showed subnormal IQ scores with marked impairment of short- and long-term memory. With respect to long-term neuropsychological outcome, our study shows that a chemotherapy-first strategy can preserve the intellectual outcome of these patients either by avoiding the need of radiotherapy or by delaying its use as much as possible.
format Text
id pubmed-2376861
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23768612009-09-10 Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy Lacaze, E Kieffer, V Streri, A Lorenzi, C Gentaz, E Habrand, J-L Dellatolas, G Kalifa, C Grill, J Br J Cancer Clinical Standard treatment of optic pathways gliomas consists of radiotherapy and surgery when feasible. Owing to the toxicity of irradiation, chemotherapy has emerged as an interesting therapeutic option, especially in young children. This study describes the neuropsychological profile of 27 children (aged between 1.5 and 15.7 years) with optic pathways gliomas treated with chemotherapy as first-line treatment. Eight of them also received radiotherapy as salvage treatment. Eight had neurofibromatosis type 1 (NF1). Intellectual outcome was preserved in children treated with chemotherapy only (mean=107±17) compared to children also receiving radiotherapy (mean IQ=88±24) or children having NF1 and treated with chemotherapy (mean IQ=80±13). Scores for abstract reasoning, mental arithmetic, chessboard/coding, perception, judgement of line orientation were lower in children irradiated than in those treated only by chemotherapy. Children with Nf1 showed subnormal IQ scores with marked impairment of short- and long-term memory. With respect to long-term neuropsychological outcome, our study shows that a chemotherapy-first strategy can preserve the intellectual outcome of these patients either by avoiding the need of radiotherapy or by delaying its use as much as possible. Nature Publishing Group 2003-12-01 2003-11-25 /pmc/articles/PMC2376861/ /pubmed/14647135 http://dx.doi.org/10.1038/sj.bjc.6601410 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Lacaze, E
Kieffer, V
Streri, A
Lorenzi, C
Gentaz, E
Habrand, J-L
Dellatolas, G
Kalifa, C
Grill, J
Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
title Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
title_full Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
title_fullStr Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
title_full_unstemmed Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
title_short Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
title_sort neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376861/
https://www.ncbi.nlm.nih.gov/pubmed/14647135
http://dx.doi.org/10.1038/sj.bjc.6601410
work_keys_str_mv AT lacazee neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy
AT kiefferv neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy
AT streria neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy
AT lorenzic neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy
AT gentaze neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy
AT habrandjl neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy
AT dellatolasg neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy
AT kalifac neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy
AT grillj neuropsychologicaloutcomeinchildrenwithopticpathwaytumourswhenfirstlinetreatmentischemotherapy